HTR1A Inhibits the Progression of Triple-Negative Breast Cancer via TGF-β Canonical and Noncanonical Pathways

RNA-seq analysis and coimmunoprecipitation assays indicated that HTR1A interacted with TRIM21 and PSMD7 to inhibit the degradation of TβRII through the ubiquitin-proteasome pathway.